| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/11/2002 | WO2002053752A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 07/11/2002 | WO2002053751A1 Polypeptides, polynucleotides, recombinant nucleic acids, recombinants, and process for producing prenyl alcohol |
| 07/11/2002 | WO2002053750A2 Inactivation of the polyphosphate kinase gene for microbial overproduction of antibiotics or enzymes |
| 07/11/2002 | WO2002053749A2 Regulation of human serine-threonine protein kinase |
| 07/11/2002 | WO2002053748A1 Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase |
| 07/11/2002 | WO2002053747A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053746A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053745A1 Process for producing prenyl alcohol |
| 07/11/2002 | WO2002053744A1 Banana actin gene and its promoter |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053741A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053739A2 Neuropilin homolog zcub5 |
| 07/11/2002 | WO2002053738A1 Novel proteins and dnas thereof |
| 07/11/2002 | WO2002053737A1 Nf-kb activating gene |
| 07/11/2002 | WO2002053736A1 Method of examining ability to control nerve cell plasticity |
| 07/11/2002 | WO2002053735A1 Trasncription activation complex and utilization thereof |
| 07/11/2002 | WO2002053734A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053732A2 Methods for making polynucleotide libraries, polynucleotide arrays, and cell librraries for high-throughput genomics analysis |
| 07/11/2002 | WO2002053731A1 Intracellular nucleic acid inhibitors of small guanine nucleotide exchange factors |
| 07/11/2002 | WO2002053729A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053727A1 Three dimensional structure of human derived apoptotic factor and receptor thereof by x-ray chrystallography and trail deletion mutant protein |
| 07/11/2002 | WO2002053726A2 Protein-protein interactions in adipocyte cells |
| 07/11/2002 | WO2002053721A1 Low-lipoxygenase 1 barley |
| 07/11/2002 | WO2002053720A1 Low-lipoxygenase 1 barley |
| 07/11/2002 | WO2002053719A2 Cytoskeleton-associated proteins |
| 07/11/2002 | WO2002053718A2 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053716A2 Regulation of human ornithine decarboxylase |
| 07/11/2002 | WO2002053714A2 Regulation of human phosphatidylinositol-4-phosphate 5-kinase |
| 07/11/2002 | WO2002053713A2 Cloning of a human sulfotransferase |
| 07/11/2002 | WO2002053712A2 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053710A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | WO2002053704A2 Protein-protein interactions |
| 07/11/2002 | WO2002053703A2 Aav2 vectors and methods |
| 07/11/2002 | WO2002053701A2 Epididymal lipocalin gene and uses thereof |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053699A2 Chondrocyte-specific and non-specific elements in the fgfr-3 promoter region |
| 07/11/2002 | WO2002053597A1 Method and specific phage library for high throughput proteomics |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053593A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/11/2002 | WO2002053591A1 Mammalian nuclear receptor cofactor cf12 and methods of use |
| 07/11/2002 | WO2002053590A1 A novel fibrinolytic enzyme the polynucleotide encoding said polypeptide and the use thereof |
| 07/11/2002 | WO2002053589A2 Nucleic acid molecules encoding dim interactors and uses therefor |
| 07/11/2002 | WO2002053588A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci |
| 07/11/2002 | WO2002053587A2 Polypeptide inducing hiv-neutralising antibodies |
| 07/11/2002 | WO2002053586A2 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 07/11/2002 | WO2002053583A2 Amphipathic peptides and their use for transferring substances of interest into cells |
| 07/11/2002 | WO2002053582A2 Process for producing peptides by using in vitrotranscription/translation system |
| 07/11/2002 | WO2002053581A2 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | WO2002053579A2 Haplotypes of the fmo2 gene |
| 07/11/2002 | WO2002053576A1 Viral delivery system for infectious transfer of large genomic dna inserts |
| 07/11/2002 | WO2002053569A1 Method of assaying lysophospholipase d activity |
| 07/11/2002 | WO2002053191A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053096A2 Single therapy and combination therapy involving drugs with target cellular proteins and drugs which target pathogen-encoded proteins |
| 07/11/2002 | WO2002052931A2 Transgenic mice containing gprc5b-like gene disruptions |
| 07/11/2002 | WO2002052924A2 Method to maintain a genic male-sterile female parental lines for the production of hybrid wheat |
| 07/11/2002 | WO2002052923A2 Long day plants transformed with phytochrome characterized by altered flowering response to day length |
| 07/11/2002 | WO2002036621A8 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 07/11/2002 | WO2002034923A8 Monocotyledon plant cells and plants which synthesise modified starch |
| 07/11/2002 | WO2002034908A3 Method for temporally controlling antisense-mediated gene inactivation |
| 07/11/2002 | WO2002034119A3 Vaccine immunotherapy for immune suppressed patients |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002030970A3 Human histone deacetylase gene |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002027315A3 Compounds with a branched linker |
| 07/11/2002 | WO2002027019A8 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 07/11/2002 | WO2002026955A3 Human proteases and polynucleotides encoding the same |
| 07/11/2002 | WO2002024933A3 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 07/11/2002 | WO2002023983A8 Method of producing non-human mammals |
| 07/11/2002 | WO2002022843A3 Nucleotide sequences which code for the dep34 gene |
| 07/11/2002 | WO2002022829A3 Nucleotide sequences which code for the ppsa gene |
| 07/11/2002 | WO2002022783A3 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 07/11/2002 | WO2002020728A3 High growth methanotrophic bacterial strain methylomonas 16a |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002016421A8 Altered ospa of borrelia burgdorferi |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008456A8 Method for identifying metastatic tumor cells |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2002000862A3 32447, a novel human acyltransferase and uses thereof |
| 07/11/2002 | WO2001096580A3 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 07/11/2002 | WO2001096375A3 33358, a novel human ankyrin family member and uses thereof |
| 07/11/2002 | WO2001094550A3 Identification and use of molecular markers indicating cellular reprogramming |
| 07/11/2002 | WO2001094548A3 Hy2 family of bilin reductases |
| 07/11/2002 | WO2001094389A3 Zcys7: a member of the cystatin superfamily |
| 07/11/2002 | WO2001087933A3 Zsig33-like peptides |
| 07/11/2002 | WO2001085970A3 Resistance to acetohydroxyacid synthase-inhibiting herbicides |
| 07/11/2002 | WO2001085925A3 Method for the production of proteins in a yeast of the genus arxula and suitable promoters |
| 07/11/2002 | WO2001083781A3 14094, a novel human trypsin family member and uses thereof |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001079445A3 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/11/2002 | WO2001078756A3 Agent for postoperative use after the removal of bone tumours |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001066752A3 Reproduction-specific genes |